Table 4.

Summary of safety outcomes – number of patient events

	DeJongste 1994	Hauvast 1998	Eddicks 2007	ESBY 1998	SpiRiT 2006
Follow up	13.8 months	6-weeks	4 weeks	2-years	1-year
SCS-related complication
Infection	NR	0/13	NR	1/57	0/34
Lead migration/fracture	6/34	0/13	NR	3/57	1/34
Mortality/morbidity
Non fatal MI	1/12	NR	NR	SCS 7/53 CABG 3/53, P = 0.18	SCS 4/34 PMR 1/34, P = 0.16
Total mortality	2/12	NR	NR	SCS 5/53 CABG 10/53, P = 0.16	SCS 4/34 PMR 2/34, P = 0.73
Cardiac mortality	2/12	NR	NR	SCS 3/53 CABG 5/53, P = 0.54	SCS 2/34 PMR 1/34, P = 0.52
Other outcomes
Treatment cross over	NR	NR	NR	6-months SCS 3/53 CABG 3/51	SCS 1/34 PMR 0/33

CABG: coronary artery bypass graft; PMR: percutaneous myocardial laser revascularisation; NR: not reported